14 research outputs found
Long-term Results of Suprapubic Bladder Neck Closure for Treatment of the Devastated Outlet
FESOTERODINE 4 AND 8 MG IMPROVE SYMPTOMS OF OVERACTIVE BLADDER: RESULTS FROM 2 POOLED PHASE III TRIALS
1007 EFFECTS OF TOLTERODINE EXTENDED RELEASE AND/OR TAMSULOSIN ON BLADDER DIARY VARIABLES AND PATIENT-REPORTED OUTCOMES IN MEN WITH LOWER URINARY TRACT SYMPTOMS INCLUDING OVERACTIVE BLADDER
Surgery for urinary incontinence in women: Report from the 6th international consultation on incontinence
Urinary incontinence is a prevalent condition worldwide and causes a tremendous impact on a woman's quality of life. While conservative and non-surgical therapies are options for treatment, surgery for stress urinary incontinence (SUI) is common. Options include colposuspension, slings (pubovaginal and midurethral), and periurethral bulking. While evidence supports each of these options in the treatment of SUI, each is associated with various rates of success and unique adverse event profiles. Urgency urinary incontinence (UUI) is initially treated with behavioral modification and pharmacologic means, with surgery reserved for those with refractory symptoms or significant complications from medication use. At present, intravesical onabotulinumtoxinA injections, percutaneous tibial nerve stimulation, and sacral neurostimulation are all viable options for refractory UUI/overactive bladder. As with surgical interventions for SUI, each of these is, likewise, associated with unique outcomes and adverse event profiles. Herein, we summarize the findings and conclusions from the 6th International Consultation on Incontinence (ICI) regarding surgical treatment of urinary incontinence in women. © 2018 Wiley Periodicals, Inc